Skip to main content
Top
Published in: Supportive Care in Cancer 6/2012

Open Access 01-06-2012 | Review Article

A systematic review of the effectiveness of qigong exercise in supportive cancer care

Authors: Cecilia L. W. Chan, Chong-Wen Wang, Rainbow T. H. Ho, Siu-Man Ng, Jessie S. M. Chan, Eric T. C. Ziea, Vivian C. W. Wong

Published in: Supportive Care in Cancer | Issue 6/2012

Login to get access

Abstract

Purpose

Qigong as a complementary and alternative modality of traditional Chinese medicine is often used by cancer patients to manage their symptoms. The aim of this systematic review is to critically evaluate the effectiveness of qigong exercise in cancer care.

Methods

Thirteen databases were searched from their inceptions through November 2010. All controlled clinical trials of qigong exercise among cancer patients were included. The strength of the evidence was evaluated for all included studies using the Oxford Centre for Evidence-based Medicine Levels of Evidence. The validity of randomized controlled trials (RCTs) was also evaluated using the Jadad Scale.

Results

Twenty-three studies including eight RCTs and fifteen non-randomized controlled clinical trials (CCTs) were identified. The effects of qigong on physical and psychosocial outcomes were examined in 14 studies and the effects on biomedical outcomes were examined in 15 studies. For physical and psychosocial outcomes, it is difficult to draw a conclusion due to heterogeneity of outcome measures and variability of the results in the included studies. Among reviewed studies on biomedical outcomes, a consistent tendency appears to emerge which suggests that the patients treated with qigong exercise in combination with conventional methods had significant improvement in immune function than the patients treated with conventional methods alone.

Conclusions

Due to high risk of bias and methodological problems in the majority of included studies, it is still too early to draw conclusive statements. Further vigorously designed large-scale RCTs with validated outcome measures are needed.
Literature
1.
go back to reference Fouladbakhsh JM, Stommel M (2010) Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol Nurs Forum 37(1):E7–E15PubMedCrossRef Fouladbakhsh JM, Stommel M (2010) Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol Nurs Forum 37(1):E7–E15PubMedCrossRef
2.
go back to reference Goldstein MS, Brown ER, Ballard-Barbash R, Morgenstern H, Bastani R, Lee J et al (2005) The use of complementary and alternative medicine among california adults with and without cancer. Evid Based Complement Alternat Med 2(4):557–565PubMedCrossRef Goldstein MS, Brown ER, Ballard-Barbash R, Morgenstern H, Bastani R, Lee J et al (2005) The use of complementary and alternative medicine among california adults with and without cancer. Evid Based Complement Alternat Med 2(4):557–565PubMedCrossRef
3.
go back to reference Molassiotis A, Scott JA, Kearney N, Pud D, Magri M, Selvekerova S, Bruyns I et al (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14(3):260–267PubMedCrossRef Molassiotis A, Scott JA, Kearney N, Pud D, Magri M, Selvekerova S, Bruyns I et al (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14(3):260–267PubMedCrossRef
4.
go back to reference Deng G, Cassileth BR, Yeung KS (2004) Complementary therapies for cancer-related symptoms. J Support Oncol 2(5):419–426, discussion 427–419PubMed Deng G, Cassileth BR, Yeung KS (2004) Complementary therapies for cancer-related symptoms. J Support Oncol 2(5):419–426, discussion 427–419PubMed
6.
go back to reference Chen K, Yeung R (2002) Exploratory studies of qigong therapy for cancer in China. Integr Cancer Ther 1(4):345–370PubMedCrossRef Chen K, Yeung R (2002) Exploratory studies of qigong therapy for cancer in China. Integr Cancer Ther 1(4):345–370PubMedCrossRef
7.
go back to reference Chen K, Yeung R (2002) A review of qigong therapy for cancer treatment. J Int Soc Life Inf Sci (ISLIS) 20(2):532 Chen K, Yeung R (2002) A review of qigong therapy for cancer treatment. J Int Soc Life Inf Sci (ISLIS) 20(2):532
8.
go back to reference Lee MS, Chen KW, Edzard E (2010) Supportive cancer care with qigong. In: Cho WCS (ed) Supportive cancer care with Chinese medicine. Springer, New York, pp 77–94CrossRef Lee MS, Chen KW, Edzard E (2010) Supportive cancer care with qigong. In: Cho WCS (ed) Supportive cancer care with Chinese medicine. Springer, New York, pp 77–94CrossRef
9.
go back to reference Lee MS, Chen KW, Sancier KM, Ernst E (2007) Qigong for cancer treatment: a systematic review of controlled clinical trials. Acta Oncol 46(6):717–722PubMedCrossRef Lee MS, Chen KW, Sancier KM, Ernst E (2007) Qigong for cancer treatment: a systematic review of controlled clinical trials. Acta Oncol 46(6):717–722PubMedCrossRef
11.
go back to reference Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12PubMedCrossRef Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12PubMedCrossRef
12.
go back to reference Jüni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323(7303):42–46PubMedCrossRef Jüni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323(7303):42–46PubMedCrossRef
13.
go back to reference Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell, ChichesterCrossRef Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell, ChichesterCrossRef
14.
go back to reference Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D (2010) Impact of medical qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol 21(3):608–614PubMedCrossRef Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D (2010) Impact of medical qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol 21(3):608–614PubMedCrossRef
15.
go back to reference Oh B, Butow P, Mullan B, Clarke S (2008) Medical qigong for cancer patients: pilot study of impact on quality of life, side effects of treatment and inflammation. Am J Chin Med 36(3):459–472PubMedCrossRef Oh B, Butow P, Mullan B, Clarke S (2008) Medical qigong for cancer patients: pilot study of impact on quality of life, side effects of treatment and inflammation. Am J Chin Med 36(3):459–472PubMedCrossRef
16.
go back to reference Lam SWY (2004) A randomized, controlled trial of Guolin qigong in patients receiving tanscatheter arterial chemoembolisation for unresectable hepatocellular carcinoma. Master's thesis. Hong Kong: University of Hong Kong Lam SWY (2004) A randomized, controlled trial of Guolin qigong in patients receiving tanscatheter arterial chemoembolisation for unresectable hepatocellular carcinoma. Master's thesis. Hong Kong: University of Hong Kong
17.
go back to reference Fu JZ, Fu SL, Qin JT (1996) Effect of qigong and anticancer body build herbs on the prognosis of postoperative patients with cardiac adenocarcinoma. 3rd World Conf Acad Exch Med Qigong, Beijing, China Fu JZ, Fu SL, Qin JT (1996) Effect of qigong and anticancer body build herbs on the prognosis of postoperative patients with cardiac adenocarcinoma. 3rd World Conf Acad Exch Med Qigong, Beijing, China
18.
go back to reference Fu JZ, Zou ZK (1995) Qigong combined with chemotherapy in the treatment of gastric cancer. In: Lin ZP (ed) Understanding of true qi cultivation and sublimation. Chinese Publisher of Constructive Materials, Beijing, pp 157–158 Fu JZ, Zou ZK (1995) Qigong combined with chemotherapy in the treatment of gastric cancer. In: Lin ZP (ed) Understanding of true qi cultivation and sublimation. Chinese Publisher of Constructive Materials, Beijing, pp 157–158
19.
go back to reference Fu JZ, Wang SM (1995) Qigong plus herbal medicine in treating late-stage stomach cancer in the elderly. In: Lin ZP (ed) Understanding of true qi cultivation and sublimation. Chinese Publisher of ConstructiveMaterials, Beijing, pp 155–157 Fu JZ, Wang SM (1995) Qigong plus herbal medicine in treating late-stage stomach cancer in the elderly. In: Lin ZP (ed) Understanding of true qi cultivation and sublimation. Chinese Publisher of ConstructiveMaterials, Beijing, pp 155–157
20.
go back to reference Wang CH, Wang BR, Shao MY, Li ZQ (1993) Clinical study of the routine treatment of cancer coordinated by qigong. 2nd World Conf Acad Exch Med Qigong, Beijing, China Wang CH, Wang BR, Shao MY, Li ZQ (1993) Clinical study of the routine treatment of cancer coordinated by qigong. 2nd World Conf Acad Exch Med Qigong, Beijing, China
21.
go back to reference Luo S, Tong T (1988) Effects of vital gate qigong on malignant tumor. 1st World Conf Acad Exch Med Qigong, Beijing, China Luo S, Tong T (1988) Effects of vital gate qigong on malignant tumor. 1st World Conf Acad Exch Med Qigong, Beijing, China
22.
go back to reference Lee TI, Chen HH, Yeh ML (2006) Effects of chan-chuang qigong on improving symptom and psychological distress in chemotherapy patients. Am J Chin Med 34:37–46PubMedCrossRef Lee TI, Chen HH, Yeh ML (2006) Effects of chan-chuang qigong on improving symptom and psychological distress in chemotherapy patients. Am J Chin Med 34:37–46PubMedCrossRef
23.
go back to reference Hong EY (2003) The effect of Yudongkong exercise in fatigue, difficulty of daily activities and symptoms of side effect in advanced gastric cancer patients receiving chemotherapy. PhD dissertion. Seoul, Korea: Yonsei University Hong EY (2003) The effect of Yudongkong exercise in fatigue, difficulty of daily activities and symptoms of side effect in advanced gastric cancer patients receiving chemotherapy. PhD dissertion. Seoul, Korea: Yonsei University
24.
go back to reference Wang Y, Ye M (2002) Analysis of psychological error factors in assessment of therapeutic effect of qigong rehabilitation in cancer patients. Acta Univ Trad Med Sinen Pharm Shanghai 16:20–22 Wang Y, Ye M (2002) Analysis of psychological error factors in assessment of therapeutic effect of qigong rehabilitation in cancer patients. Acta Univ Trad Med Sinen Pharm Shanghai 16:20–22
25.
go back to reference Fu JZ (1993) Treatment of advanced gastric cancer in the aged by the combination of qigong and medical herbs. 2nd World Conf Acad Exch Med Qigong, Beijing, China Fu JZ (1993) Treatment of advanced gastric cancer in the aged by the combination of qigong and medical herbs. 2nd World Conf Acad Exch Med Qigong, Beijing, China
26.
go back to reference Zheng RR (1990) Observation of 100 cases with comprehensive qigong therapy for treating later-stage cancer. World Qigong 3:19 Zheng RR (1990) Observation of 100 cases with comprehensive qigong therapy for treating later-stage cancer. World Qigong 3:19
27.
go back to reference Peng ZS, Chen XY, Wen YZ, Ni YW, Deng GY (1989) Clinical observation of 20 patients with malignant gastrointestinal tumors treated by supplementary Qigong. 2nd Int Conf on Qigong, Xi'an, China Peng ZS, Chen XY, Wen YZ, Ni YW, Deng GY (1989) Clinical observation of 20 patients with malignant gastrointestinal tumors treated by supplementary Qigong. 2nd Int Conf on Qigong, Xi'an, China
28.
go back to reference Sun QZ, Zhao L (1988) Clinical observation of qigong as a therapeutic aid for advanced cancer patients. 1st World Conf Acad Exch Med Qigong, Beijing, China Sun QZ, Zhao L (1988) Clinical observation of qigong as a therapeutic aid for advanced cancer patients. 1st World Conf Acad Exch Med Qigong, Beijing, China
29.
go back to reference Yeh ML, Lee TI, Chen HH, Chao TY (2006) The influences of Chan-Chuang qi-gong therapy on complete blood cell counts in breast cancer patients treated with chemotherapy. Cancer Nurs 29(2):149–155PubMedCrossRef Yeh ML, Lee TI, Chen HH, Chao TY (2006) The influences of Chan-Chuang qi-gong therapy on complete blood cell counts in breast cancer patients treated with chemotherapy. Cancer Nurs 29(2):149–155PubMedCrossRef
30.
go back to reference Yu H (1996) The effect of Qigong exercise on anti-oxidant capacity among cancer patients. Chin J Sports Med 03:233 Yu H (1996) The effect of Qigong exercise on anti-oxidant capacity among cancer patients. Chin J Sports Med 03:233
31.
go back to reference Ye M, Wang Y, Mao CX, Zhang RH (1992) The effect of qigong exercise on unscheduled DNA synthesis of the peripheral blood lymphocytes of cancer patients. 4th International Symposium on Qigong, Shanghai, China Ye M, Wang Y, Mao CX, Zhang RH (1992) The effect of qigong exercise on unscheduled DNA synthesis of the peripheral blood lymphocytes of cancer patients. 4th International Symposium on Qigong, Shanghai, China
32.
go back to reference Lo J, He C, Lu H, Wang L (1990) Changes of peripheral blood cell population and immune functions in 31 nasopharyngeal carcinoma (NPC) patients treated with radiotherapy and qigong. 3rd Nat Acad Conf on Qigong Science, Guangzhou, China Lo J, He C, Lu H, Wang L (1990) Changes of peripheral blood cell population and immune functions in 31 nasopharyngeal carcinoma (NPC) patients treated with radiotherapy and qigong. 3rd Nat Acad Conf on Qigong Science, Guangzhou, China
33.
go back to reference Qi YQ (1989) Changes of lymphocytes lipase in cancer patients treated with Qigong and Chinese medicine. J Nanjing Univ Trad Chin Med 01:40 Qi YQ (1989) Changes of lymphocytes lipase in cancer patients treated with Qigong and Chinese medicine. J Nanjing Univ Trad Chin Med 01:40
34.
go back to reference Xu H, Xue H, Zhang C, Zhou Q, Shao X (1990) Clinical study of the effect of qigong practice on the Cu-Zn SOD activity in cancer patients. 3rd Nat Acad Conf on Qigong Science, Guangzhou, China Xu H, Xue H, Zhang C, Zhou Q, Shao X (1990) Clinical study of the effect of qigong practice on the Cu-Zn SOD activity in cancer patients. 3rd Nat Acad Conf on Qigong Science, Guangzhou, China
35.
go back to reference Xu HF, Qi YQ (1989) Preliminary study on qigong and immunity. 2nd Int Conf on Qigong, Xi'an, China Xu HF, Qi YQ (1989) Preliminary study on qigong and immunity. 2nd Int Conf on Qigong, Xi'an, China
36.
go back to reference Xu HF, Wang GM, Xue HH, Zhanbg CM, Wang JM, Qi YQ (1988) Observation of T lymphocytes by ANAE staining in the clinical application of qigong. 1st World Conf Acad Exch Med Qigong, Beijing, China Xu HF, Wang GM, Xue HH, Zhanbg CM, Wang JM, Qi YQ (1988) Observation of T lymphocytes by ANAE staining in the clinical application of qigong. 1st World Conf Acad Exch Med Qigong, Beijing, China
37.
go back to reference Jette M, Sidney K, Blumchen G (1990) Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol 13(8):555–565PubMedCrossRef Jette M, Sidney K, Blumchen G (1990) Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol 13(8):555–565PubMedCrossRef
Metadata
Title
A systematic review of the effectiveness of qigong exercise in supportive cancer care
Authors
Cecilia L. W. Chan
Chong-Wen Wang
Rainbow T. H. Ho
Siu-Man Ng
Jessie S. M. Chan
Eric T. C. Ziea
Vivian C. W. Wong
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 6/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1378-3

Other articles of this Issue 6/2012

Supportive Care in Cancer 6/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine